Comet Therapeutics
Cambridge
About Comet Therapeutics
CoEnzyme is a developer of therapies designed to treat orphan neurological disorders. The company develops a treatment to restore dysregulated CoEnzyme A metabolism through its CoEnzyme metabolism platform, enabling physicians to address the profound unmet medical needs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $28.5M
- Funding stage: M&A
- Last round: Series A (Jun 2019)
- Website: comettherapeutics.com
Industries & Categories
Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/comet-therapeutics-133686 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.